Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation

J Thorac Oncol. 2010 Dec;5(12):2039-40. doi: 10.1097/JTO.0b013e3181f43274.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / genetics
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • ErbB Receptors / genetics*
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Mutation*
  • Oncogene Proteins, Fusion / genetics*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • EML4-ALK fusion protein, human
  • Oncogene Proteins, Fusion
  • Quinazolines
  • ErbB Receptors
  • Gefitinib